Abstract
No public abstract is available from the verified source records.
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureAbstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
10.3322/caac.21262
10.3322/caac.21262
Progression of clinical and laboratory studies on systemic chemotherapy with oxiliplatin-combined regimens in advanced hepatocellular carcinoma.
2014
10.1056/nejmoa0708857
10.1056/nejmoa0708857
10.1016/s1470-2045(08)70285-7
10.1016/s1470-2045(08)70285-7
10.1200/jco.2012.44.5643
10.1200/jco.2012.44.5643
10.1634/theoncologist.2014-0190
10.1634/theoncologist.2014-0190
Clinical study on FOLFOX 4 regimen as systemic chemotherapy for advanced primary liver carcinoma.
2013
10.1007/s10330-011-0934-0
10.1007/s10330-011-0934-0
Intra-tumoral injection of E1B gene-deleted adenovirus combined with FOLFOX4 for advanced hepatocellular carcinoma.
2012
Unresolved referenced work
2011
Unresolved referenced work
Kept as external metadata until matched
10.1016/j.jhep.2012.09.006
10.1016/j.jhep.2012.09.006
10.3747/co.v18i1.708
10.3747/co.v18i1.708
10.1038/onc.2009.356
10.1038/onc.2009.356
10.1016/j.clon.2014.04.031
10.1016/j.clon.2014.04.031
Antiviral treatment in HBV/HCV related HCC expert consensus.
2014
Drug development for hepatocellular carcinoma: knowing the past help to understand the future.
2014
Sorafenib (S) alone versus S combined with gemcitabine and oxaliplatin (GEMOX) in first-line treatment of advanced hepatocellular carcinoma (HCC): final analysis of the randomized Phase II GONEXT trial (UNICANCER/FFCD PRODIGE 10 trial).
10.1200/jco.2013.31.15_suppl.4028 · 2013
A multicenter Phase II study of sorafenib, capecitabine, and oxaliplatin (SECOX) in patients with advanced hepatocellular carcinoma: final results of Hong Kong-Singapore Hepatocellular Carcinoma Research Collaborative Group study.
2013
Systemic therapy for hepatocellular carcinoma.
2013
No additional external references are available.